Cargando…
Association of Superficial Cartilage Transverse Relaxation Time With Osteoarthritis Disease Progression: Data From the Foundation for the National Institutes of Health Biomarker Study of the Osteoarthritis Initiative
OBJECTIVE: To study whether layer‐specific cartilage transverse relaxation time (T2) and/or longitudinal change is associated with clinically relevant knee osteoarthritis (OA) disease progression. METHODS: The Foundation for the National Institutes of Health Biomarker Consortium was a nested case–co...
Autores principales: | Fuerst, David, Wirth, Wolfgang, Gaisberger, Martin, Hunter, David J., Eckstein, Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578581/ https://www.ncbi.nlm.nih.gov/pubmed/33973402 http://dx.doi.org/10.1002/acr.24627 |
Ejemplares similares
-
Detection of Differences in Longitudinal Cartilage Thickness Loss Using a Deep‐Learning Automated Segmentation Algorithm: Data From the Foundation for the National Institutes of Health Biomarkers Study of the Osteoarthritis Initiative
por: Eckstein, Felix, et al.
Publicado: (2022) -
Characterization of the Cartilage DNA Methylome in Knee and Hip Osteoarthritis
por: Rushton, Michael D, et al.
Publicado: (2014) -
Brief Report: Intraarticular Sprifermin Not Only Increases Cartilage Thickness, but Also Reduces Cartilage Loss: Location‐Independent Post Hoc Analysis Using Magnetic Resonance Imaging
por: Eckstein, Felix, et al.
Publicado: (2015) -
Discovery of an autoantibody signature for the early diagnosis of knee osteoarthritis: data from the Osteoarthritis Initiative
por: Camacho-Encina, María, et al.
Publicado: (2019) -
Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of location in the femorotibial joint: post-hoc analysis of a randomised, placebo-controlled phase II clinical trial
por: Eckstein, Felix, et al.
Publicado: (2020)